CORT
NASDAQ
US
Corcept Therapeutics Incorporated - Common Stock
$42,49
▲ +$0,51
(+1,21%)
Vol 1.5M
11
Skor Kualitas
ok
Pemeriksaan Mendalam
2/5
ok
Pendapatan ✓
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$3.7B
P/E
34,5
ROE
16,1%
Margin
14,3%
D/E
0,00
Beta
0,18
52W
$49–$117
Konsensus Wall Street
12 analis · Apr 20262
Beli Kuat
7
Beli
3
Tahan
0
Jual
0
Jual Kuat
75,0%
Peringkat Beli
Grafik Harga
Saham Serupa
AXSM
Axsome Therapeutics Inc
$9.2B
BLTE
Belite Bio Inc
$5.6B
TERN
Terns Pharmaceuticals Inc
$4.3B
LGND
Ligand Pharmaceuticals Inc
P/E 76,6
$3.7B
AMRX
Amneal Pharmaceuticals Inc
P/E 671,4
$4.0B
CRNX
Crinetics Pharmaceuticals Inc
$4.4B
INDV
Indivior Pharmaceuticals, Inc
P/E 35,8
$4.5B
GPCR
Structure Therapeutics Inc
$4.2B
EWTX
Edgewise Therapeutics Inc
$2.6B
Pendapatan
Tingkat beat: 75,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,31 | $0,20 | $-0,11 |
| Sep 2025 | $0,14 | $0,16 | +$0,02 |
| Jun 2025 | $0,19 | $0,29 | +$0,10 |
| Mar 2025 | $0,15 | $0,17 | +$0,02 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $181.9M | $157.2M | $194.4M | $207.6M | $202.1M |
| Laba Bersih | — | $30.7M | $20.5M | $35.1M | $19.7M | $24.3M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 20.3% | 20.3% | 20.3% | 20.3% | 16.1% | 16.1% |
| P/E (TTM) | 58.24 | 55.72 | 67.13 | 57.92 | 78.80 | 34.50 |
| Net Margin | 18.1% | 18.7% | 18.7% | 18.7% | 14.3% | 14.3% |
| Gross Margin | 98.2% | 98.4% | 98.4% | 98.4% | 98.2% | 98.2% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.06 | 3.06 | 3.06 | 3.06 | 3.14 | 3.14 |
Rasio Utama
ROA (TTM)
12,8%
P/S (TTM)
4,94
P/B
7,8
EPS (TTM)
$0,89
CF/Share
$0,81
Pertumbuhan Pendapatan 3T
+22,6%
52W High
$117,33
52W Low
$49,00
$49,00
Rentang 52 Minggu
$117,33
Kesehatan Keuangan
Arus Kas Bebas
$38.4M
Utang Bersih
-$114.4M
Kas
$120.5M
Total Utang
$6.1M
Per tanggal Des 31, 2025
Як CORT виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Mid-cap Pharmaceuticals ($2B+) · 25 компаній
Оцінка CORT vs аналоги Pharmaceuticals
P/E
34,5
▲
13%
di atas
rekan
(30,7)
vs Rekan
vs Industri
Undervalued
P/S
4,9
▼
27%
di bawah
rekan
(6,7)
vs Rekan
vs Industri
Lebih mahal
P/B
7,8
▲
49%
di atas
rekan
(5,2)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(3,1%)
vs Rekan
vs Industri
Yield rendah
Прибутковість CORT vs аналоги Pharmaceuticals
ROE
16,1%
▲
162%
di atas
rekan
(-26,1%)
vs Rekan
vs Industri
Tingkat atas
Net margin
14,3%
▲
1088%
di atas
rekan
(-1,5%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
98,2%
▲
10%
di atas
rekan
(88,9%)
vs Rekan
vs Industri
Sejajar
ROA
12,8%
▲
236%
di atas
rekan
(-9,5%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя CORT vs аналоги Pharmaceuticals
D/E ratio
0,0
▼
100%
di bawah
rekan
(27,4)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
3,1
▼
10%
di bawah
rekan
(3,5)
vs Rekan
vs Industri
Sejajar
Beta
0,2
▼
70%
di bawah
rekan
(0,6)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів CORT
CORT
Median rekan
Industri
CORT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CORT vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
BELANOFF JOSEPH K
Chief Executive Officer · Mar 25
26198 shs
GUYER WILLIAM
Officer · Mar 20
11767 shs
GUYER WILLIAM
Officer · Mar 20
11767 shs
WILSON JAMES N
Director · Mar 20
4000 shs
BAKER GEORGE LEONARD JR.
Director · Mar 17
100000 shs
MAHONEY DAVID L
Director · Mar 13
30000 shs
WILSON JAMES N
Director · Mar 13
28000 shs
MAHONEY DAVID L
Director · Mar 13
24531 shs
GUYER WILLIAM
Officer · Mar 04
8233 shs
GUYER WILLIAM
Officer · Mar 04
8233 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 36,09%Blackrock Inc.
11,34%
$453.5M
Vanguard Group Inc
8,93%
$357.0M
Ingalls & Snyder LLC
6,76%
$270.5M
Renaissance Technologies, L…
5,41%
$216.5M
Parallel Advisors, LLC
3,65%
$145.9M
Per tanggal Des 31, 2025